Paper · 41545741
The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.
Demnitz-King H and 41 others. Nat Rev Neurol, 2026. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process. Papers, record 41545741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545741
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dementia | Major topic |
| Risk Reduction Behavior | Major topic |
| Delphi Technique | Major topic |
| Health Policy | Major topic |
| Humans | |
| England |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,696,263 | The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/38696263 | PubMed |
| 2 | 37,095,484 | Dissemination of public health research to prevent non-communicable diseases: a scoping review. | BMC Public Health | 2023 | https://conductscience.org/library/papers/37095484 | PubMed |
| 3 | 39,840,755 | South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trial. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/39840755 | PubMed |
| 4 | 32,611,641 | Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. | Neurology | 2020 | https://conductscience.org/library/papers/32611641 | PubMed |
| 5 | 33,573,595 | Conceptualising natural and quasi experiments in public health. | BMC Med Res Methodol | 2021 | https://conductscience.org/library/papers/33573595 | PubMed |
| 6 | 39,096,926 | Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. | Lancet | 2024 | https://conductscience.org/library/papers/39096926 | PubMed |
| 7 | 39,930,073 | Nothing about us, without us - establishing a patient and public involvement and engagement group. | Nat Rev Neurol | 2025 | https://conductscience.org/library/papers/39930073 | PubMed |
| 8 | 34,534,250 | General population perspectives of dementia risk reduction and the implications for intervention: A systematic review and thematic synthesis of qualitative evidence. | PLoS One | 2021 | https://conductscience.org/library/papers/34534250 | PubMed |
| 9 | 39,779,661 | Prevention Is Better Than Cure: Public Understanding of Preventing Neurodegenerative Disorders. | Int J Geriatr Psychiatry | 2025 | https://conductscience.org/library/papers/39779661 | PubMed |
| 10 | 27,297,373 | The use of Delphi and Nominal Group Technique in nursing education: A review. | Int J Nurs Stud | 2016 | https://conductscience.org/library/papers/27297373 | PubMed |
1 to 10 of 42
See all 42 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,831,924 | The causal relationship between immune cells, white matter microstructure and dementia: a Mendelian randomization study and co-localization analysis. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/42831924 | PubMed |
| 42,535,325 | From mapping evidence to engaging voices: Paving the way for research on the social determinants of dementia. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42535325 | PubMed |
| 42,048,404 | The principles of Population-Level Approaches to Dementia Risk Reduction (PLADRR). | PLoS Med | 2026 | https://conductscience.org/library/papers/42048404 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545741
GET https://conductscience.org/api/papers/v1/41545741/authors?page=2